Logo image of RCT

REDCLOUD HOLDINGS PLC (RCT) Stock Fundamental Analysis

NASDAQ:RCT - Nasdaq - GB00BMCD0001 - Common Stock - Currency: USD

2.86  -1.43 (-33.33%)

After market: 2.91 +0.05 (+1.75%)

Fundamental Rating

0

Taking everything into account, RCT scores 0 out of 10 in our fundamental rating. RCT was compared to 0 industry peers in the Unkown industry. RCT may be in some trouble as it scores bad on both profitability and health. RCT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RCT had negative earnings in the past year.
In the past year RCT has reported a negative cash flow from operations.
RCT Yearly Net Income VS EBIT VS OCF VS FCFRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

Industry RankSector Rank
ROA -288.81%
ROE N/A
ROIC N/A
ROA(3y)-313.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCT Yearly ROA, ROE, ROICRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

RCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCT Yearly Profit, Operating, Gross MarginsRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

0

2. Health

2.1 Basic Checks

RCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RCT has about the same amount of shares outstanding.
Compared to 1 year ago, RCT has a worse debt to assets ratio.
RCT Yearly Shares OutstandingRCT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M
RCT Yearly Total Debt VS Total AssetsRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

RCT has an Altman-Z score of -18.75. This is a bad value and indicates that RCT is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.75
ROIC/WACCN/A
WACC9.49%
RCT Yearly LT Debt VS Equity VS FCFRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M -40M -60M

2.3 Liquidity

RCT has a Current Ratio of 0.17. This is a bad value and indicates that RCT is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.17 indicates that RCT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
RCT Yearly Current Assets VS Current LiabilitesRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for RCT have decreased strongly by -56.59% in the last year.
RCT shows a strong growth in Revenue. In the last year, the Revenue has grown by 134.76%.
EPS 1Y (TTM)-56.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.59%
Revenue 1Y (TTM)134.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%134.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCT Yearly Revenue VS EstimatesRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCT Price Earnings VS Forward Price EarningsRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCT Per share dataRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REDCLOUD HOLDINGS PLC

NASDAQ:RCT (7/2/2025, 4:06:07 PM)

After market: 2.91 +0.05 (+1.75%)

2.86

-1.43 (-33.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.58%
Inst Owner ChangeN/A
Ins Owners84.84%
Ins Owner ChangeN/A
Market Cap126.50M
AnalystsN/A
Price TargetN/A
Short Float %0.45%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.72
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS1.05
BVpS-1.55
TBVpS-1.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -288.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-313.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 206.87%
Cap/Sales 8.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -18.75
F-Score4
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)133.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)13.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)134.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%134.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-50.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.64%
OCF growth 3YN/A
OCF growth 5YN/A